医药生物行业周报:国产减肥药获批上市 关注产业链相关机会

光大证券
30 Jun

行情回顾:上周,A 股医药生物指数上涨1.60%,跑输沪深300 指数0.35pp,跑输创业板综指4.11pp,在31 个子行业中排名第23,表现一般。港股恒生医疗健康指数上周收涨2.85%,跑赢恒生国企指数0.09pp。上市公司研发进度跟踪:上周,海思科的HSK47388 片的IND 申请新进承办;智翔金泰的GR2303 注射液、正大天晴的注射用TQB2934 的临床申请新进承办。恒瑞医药的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10